Clinical Study
Exposure to Ti4Al4V Titanium Alloy Leads to Redox Abnormalities, Oxidative Stress, and Oxidative Damage in Patients Treated for Mandible Fractures
Table 1
Clinical characteristics of patients with titanium mandibular fixations and healthy controls.
| Serum/plasma | Control group | Study group | Mean | SD | Geometric mean | Lower 95% CI of mean | Upper 95% CI of mean | Mean | SD | Geometric mean | Lower 95% CI of mean | Upper 95% CI of mean |
| WBC ×103/μL | 7.530 | 1.958 | 7.278 | 6.841 | 8.219 | 6.917 | 1.709 | 6.756 | 6.315 | 13.232 | RBC ×106/μL | 5.207 | 0.411 | 5.193 | 5.062 | 5.352 | 5.070 | 0.264 | 5.064 | 4.977 | 10.047 | HGB g/dL | 15.270 | 1.027 | 15.240 | 14.908 | 15.632 | 15.320 | 0.720 | 15.300 | 15.067 | 30.387 | HCT % | 45.230 | 2.630 | 45.160 | 44.304 | 46.156 | 45.550 | 2.123 | 45.510 | 44.803 | 90.353 | MCV fL | 87.140 | 3.817 | 87.070 | 85.796 | 88.484 | 89.630 | 3.549 | 89.570 | 88.381 | 178.011 | MCHC g/dL | 33.760 | 0.918 | 33.750 | 33.437 | 34.083 | 33.650 | 1.524 | 33.620 | 33.114 | 66.764 | PLT ×103/μL | 230.700 | 43.800 | 227.100 | 215.282 | 246.118 | 228.300 | 23.380 | 227.300 | 220.070 | 448.370 | PT s | 12.230 | 0.624 | 12.220 | 12.010 | 12.450 | 11.660 | 0.699 | 11.640 | 11.414 | 23.074 | INR | 0.935 | 0.077 | 0.933 | 0.908 | 0.962 | 0.908 | 0.072 | 0.906 | 0.883 | 1.791 | APTT s | 27.640 | 1.468 | 27.610 | 27.123 | 28.157 | 26.780 | 3.809 | 26.550 | 25.439 | 52.219 | Na+ mmol/L | 140.700 | 1.890 | 140.700 | 140.035 | 141.365 | 139.800 | 1.184 | 139.800 | 139.383 | 279.183 | K+ mmol/L | 4.363 | 0.317 | 4.353 | 4.251 | 4.475 | 4.390 | 0.215 | 4.386 | 4.314 | 8.704 | CRP mg/L | 1.050 | 0.370 | 1.002 | 0.920 | 1.180 | 1.000 | 0.548 | 0.880 | 0.807 | 1.807 |
|
|
∗Statistical significance , study group versus control. |